| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.024 | 0.9 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |